In this study, we constructed the Bax-Anti Bcl2 combination module driven by artificial hTERT promoter which could over express Bax and knockdown of Bcl2 and tested the ability of this module in selectively indentifying and killing bladder cancer cells. The gene discussed is BCL2; the disease is urinary bladder cancer.